https://european-biotechnology.net/wp-content/uploads/2024/08/Shigella-e1722501749960.png
274
487
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk 2024-08-01 08:43:37 2024-08-01 08:43:37 Valneva licences LimmaTech’s Shigella vaccine
https://european-biotechnology.net/wp-content/uploads/2024/07/SIAT-1030x348-1.png
348
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk 2024-07-31 06:09:38 2024-07-31 06:09:38 BI Venture Funds invests in oncolytic bacteria
https://european-biotechnology.net/wp-content/uploads/2024/07/GlaxoSmithKline_Headquarters_on_the_Great_West_Road_in_Brentford_-_panoramio-1030x684-1.png
684
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk 2024-07-30 05:57:33 2024-07-30 15:02:01 GSK and Flagship Pioneering ink US$7.2bn biobucks discovery deal
https://european-biotechnology.net/wp-content/uploads/2024/07/GOURMEY-Foie-gras-Mi-cuit-branded-Credits-to-Romain-Buisson-1030x541-1.png
541
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk 2024-07-26 09:47:37 2024-07-30 15:02:01 Gourmey files first EU application for cell-based meat
https://european-biotechnology.net/wp-content/uploads/2024/07/Confo-Therapeutics-CEO-Cedric-Ververken-e1721974284266.jpg
338
600
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk 2024-07-26 06:11:54 2024-07-30 15:02:01 Confo Therapeutics closes €60m Series B financing
https://european-biotechnology.net/wp-content/uploads/2024/07/ac_immune_cover-1030x688-1.jpg
688
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk 2024-07-25 11:10:09 2024-07-30 15:02:01 AC Immune bags FDA fast track designation
https://european-biotechnology.net/wp-content/uploads/2024/07/MultiplesMyelom_©_Jan_Kronke_cf3ce58c64-1030x515-1.jpg
515
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk 2024-07-23 07:09:41 2024-07-30 15:02:02 New targets for incurable blood cancer
https://european-biotechnology.net/wp-content/uploads/2024/07/Evotec_Verona-1030x515-1.jpeg
515
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk 2024-07-23 05:31:33 2024-07-30 15:02:02 SynaptixBio Ltd and Evotec SE expand collaboration
https://european-biotechnology.net/wp-content/uploads/2024/07/von-der-Leyen-EB-1030x687-1.jpg
687
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk 2024-07-21 11:16:44 2024-07-30 15:02:02 Von der Leyen: no mention of biotechnology
https://european-biotechnology.net/wp-content/uploads/2024/07/Micropig-4-months_Ellegaard_jpg-e1721392803620.png
270
481
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk 2024-07-21 07:36:45 2024-07-30 15:02:02 Scientists prevent transplant rejection
Scroll to top
Scroll to top
Scroll to top
